Market Overview

UPDATE: Tigress Initiates Coverage On Illumina

Related ILMN
How Is Viking Global Beating The Market?
Benzinga's Top Initiations
Gilead, Netflix Among Week's Top Inside Stock Trades (Investor's Business Daily)

In a report released Friday, Tigress analyst Philip Van Deusen initiated coverage on Illumina (NASDAQ: ILMN) with a Buy rating.

Analysts at Tigress favor Illumina for reducing costs in its genomic health progress with its genetic testing, diagnosis and individualized treatment. Illumina's development of hardware will strengthen, influencing an increase to barriers to entry. Tigress holds high expectations for Illumina sequencing machines, growing 51 percent year over year and making a majority of the company's revenue.

Latest Ratings for ILMN

Aug 2015Cantor FitzgeraldInitiates Coverage onBuy
Aug 2015Mizuho SecuritiesReinstatesBuy
Jul 2015Janney CapitalDowngradesBuyNeutral

View More Analyst Ratings for ILMN
View the Latest Analyst Ratings

Posted-In: Philip Van Deusen TigressInitiation Analyst Ratings


Related Articles (ILMN)

View Comments and Join the Discussion!

Get Benzinga's Newsletters